Recursion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Recursion (Nasdaq: RXRX) announced participation in two upcoming investor conferences in November 2025. The company will present at the Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, November 11, 2025 and at the Jefferies Global Healthcare Conference London on Tuesday, November 18, 2025. Webcasts will be available in the events section of Recursion's investor relations website at ir.recursion.com.

News Market Reaction

-8.09%

16 alerts

-8.09% News Effect

+3.8% Peak Tracked

-11.0% Trough Tracked

-$208M Valuation Impact

$2.36B Market Cap

321K Volume

On the day this news was published, RXRX declined 8.09%, reflecting a notable negative market reaction. Argus tracked a peak move of +3.8% during that session. Argus tracked a trough of -11.0% from its starting point during tracking. Our momentum scanner triggered 16 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $208M from the company's valuation, bringing the market cap to $2.36B at that time.

Data tracked by StockTitan Argus on the day of publication.

Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following upcoming investor conferences:

• Guggenheim 2nd Annual Healthcare Innovation Conference — Tuesday, November 11, 2025
• Jefferies Global Healthcare Conference London — Tuesday, November 18, 2025

Webcasts may be found in the events section of the Recursion Investor Relations website at ir.recursion.com.
About Recursion
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.
Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area. Learn more at www.Recursion.com, or connect on X and LinkedIn.

Investor Contact
investor@recursion.com

Media Contact
media@recursion.com

FAQ

When will Recursion (RXRX) present at the Guggenheim Healthcare Innovation Conference?

Recursion will present on Tuesday, November 11, 2025.

When is Recursion (RXRX) scheduled to present at the Jefferies Global Healthcare Conference London?

Recursion is scheduled to present on Tuesday, November 18, 2025.

Where can investors watch Recursion (RXRX) conference webcasts?

Webcasts will be available in the events section of the Recursion investor relations website at ir.recursion.com.

What is the ticker symbol for Recursion attending the November 2025 conferences?

The ticker symbol is RXRX on Nasdaq.

Are the Recursion (RXRX) conference presentations open to the public via webcast?

Yes. The announcement indicates webcasts will be posted on the company's investor relations events page.

Will the Recursion (RXRX) presentations include clinical updates or new data?

The announcement lists conference participation only and does not specify content or clinical data details.